These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11061851)

  • 1. An evaluation of the process and costs associated with targeted lookbacks for HCV and general notification of transfusion recipients.
    Callum JL; Pinkerton PH; Coovadia AS; Thomson AE; Dewsbury F
    Transfusion; 2000 Oct; 40(10):1169-75. PubMed ID: 11061851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of a hepatitis C general transfusion lookback program for patients who received blood products before July 1992.
    Williams JL; Cagle HH; Christensen CJ; Fox-Leyva LK; McMahon BJ
    Transfusion; 2005 Jun; 45(6):1020-6. PubMed ID: 15935002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCV lookback in the United States: effectiveness of an extended lookback program.
    Menozzi D; Udulutch T; Llosa AE; Galel SA
    Transfusion; 2000 Nov; 40(11):1393-8. PubMed ID: 11099671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the effectiveness of targeted lookback for HCV infection in the United States-interim results.
    Culver DH; Alter MJ; Mullan RJ; Margolis HS
    Transfusion; 2000 Oct; 40(10):1176-81. PubMed ID: 11061852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C lookback in Canada.
    Goldman M; Long A
    Vox Sang; 2000; 78 Suppl 2():249-52. PubMed ID: 10938962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Canadian experience with targeted hepatitis C virus lookback.
    Goldman M; Patterson L; Long A
    Transfusion; 2006 May; 46(5):690-4. PubMed ID: 16686835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted hepatitis C lookback: Quebec, Canada.
    Long A; Spurll G; Demers H; Goldman M
    Transfusion; 1999 Feb; 39(2):194-200. PubMed ID: 10037131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective targeted HCV lookback using centralized contracted notification service.
    Saxena S; Shulman IA; Pachciarz J; Downey N; Figueroa PI
    Transfusion; 2003 Jun; 43(6):799-805. PubMed ID: 12757532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health and economic consequences of HCV lookback.
    Pereira A
    Transfusion; 2001 Jun; 41(6):832-9. PubMed ID: 11399829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion-acquired hepatitis C: the Danish lookback experience. The Danish HCV [hepatitis C virus] Lookback Group.
    Christensen PB; Groenbaek K; Krarup HB
    Transfusion; 1999 Feb; 39(2):188-93. PubMed ID: 10037130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probability of receiving testing in a national lookback program: the English HCV experience.
    Transfusion; 2002 Sep; 42(9):1140-5. PubMed ID: 12430670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of general hepatitis C virus lookbacks in Canada.
    Bowker SL; Smith LJ; Rosychuk RJ; Preiksaitis JK
    Vox Sang; 2004 Jan; 86(1):21-7. PubMed ID: 14984556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.
    Davoren A; Dillon AD; Power JP; Donnellan J; Quinn JM; Willis JW; Lawlor EM; O'Riordan JM
    Transfusion; 2002 Nov; 42(11):1501-6. PubMed ID: 12421225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood recipient notification for hepatitis C in Prince Edward Island.
    Van Til LD; Sweet LE
    CMAJ; 2000 Jan; 162(2):199-202. PubMed ID: 10674052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current good manufacturing practice for blood and blood components; notification of consignees and transfusion recipients receiving blood and blood components at increased risk of transmitting hepatitis C virus infection ("lookback"). Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Aug; 72(164):48765-801. PubMed ID: 17886394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion transmission of HCV infection before anti-HCV testing of blood donations in England: results of the national HCV lookback program.
    Transfusion; 2002 Sep; 42(9):1146-53. PubMed ID: 12430671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C lookback programme: a single hospital experience.
    Pawson R; Rajan S; Hazlehurst G; Dusheiko G; Miller R; Hewitt P; Mehta A
    Transfus Med; 1999 Sep; 9(3):189-93. PubMed ID: 10555811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectivity of pre-seroconversion donations: an analysis of lookback exercises in The Netherlands, 2000-2006.
    Lieshout-Krikke RW; van 't Ende EA; Slot E; Karomi S; Kivit RM; Zaaijer HL
    Vox Sang; 2012 Apr; 102(3):193-7. PubMed ID: 21883273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the impact of public health notification of suspected transfusion-transmissible hepatitis C virus infection and effectiveness of lookback and traceback investigations by Canadian Blood Services in British Columbia, Canada, August 2002 through February 2005.
    Whitlock M; Lord S; Buxton JA; Doyle P; Bigham M
    Transfusion; 2007 Aug; 47(8):1534-9. PubMed ID: 17655599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transfusion-related hepatitis C. The Danish "look back" survey].
    Christensen PB; Grønbaek KE; Krarup HB
    Ugeskr Laeger; 2000 May; 162(18):2554-7. PubMed ID: 10846954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.